NEW YORK (Reuters Health) - High-dose intravenously administered vitamin C apparently led to longer-than-expected survival in three patients with advanced cancer, doctors at the National Institutes of Health in Bethesda, Maryland and colleagues in Canada report. Two of the three patients are still alive without evidence of disease.
In the three cases described in the Canadian Medical Association Journal, vitamin C was given intravenously at doses ranging from 15 to 65 grams to produce plasma concentrations that cannot be achieved by taking vitamin C by mouth.
Link to article
No comments:
Post a Comment